Altered liver expression of genes involved in lipid and glucose metabolism in mice with partial IGF-1 deficiency: an experimental approach to metabolic syndrome
AuthorsRodríguez de Ita, Julieta
Castilla Cortázar, Isabel
Aguirre, G. A
Sánchez Yago, C.
Santos Ruiz, M. O
Guerra Menéndez, L.
Martín Estal, I.
García Magariño, M.
Lara Díaz, Victor J.
Puche, J. E
DisciplineCiencias de la Salud / Health Sciences
Type 2 diabetes
MetadataShow full item record
AbstractAbstract Background Insulin growth factor 1 (IGF-1) has multiple effects on metabolism. Much evidence suggests that the deficiency of this hormone increases insulin resistance, impairs lipid metabolism, augments oxidative damage and deregulates the neuro-hormonal axis. An inverse relationship between IGF-1 levels and the prevalence of Metabolic Syndrome (MetS) with its cardiovascular complications has been identified. However, the underlying mechanisms linking IGF-1 and MetS are still poorly understood. In order to elucidate such mechanisms, the aim of this work was to study, in mice with partial IGF-1 deficiency, liver expression of genes involved in glucose and lipid metabolism as well as serum levels of glucose, triglycerides and cholesterol, as well as liver malondialdehyde (MDA) levels, as a marker for oxidative damage. Methods Three experimental groups were studied in parallel: Controls (CO), wild type mice (igf-1 +/+); untreated heterozygous mice (Hz, igf-1 +/−) and Hz (igf-1 +/−) mice treated with low doses of IGF-1 for 10 days (Hz + IGF-1). Results A reduction of IGF-1 serum levels in the Hz group was found, which was normalized by IGF-1 therapy. Serum levels of glucose, triglycerides and cholesterol were significantly increased in the untreated Hz group as compared to both controls and Hz + IGF-1 groups. The expression of genes involved in gluconeogenesis, glycogenolysis, lipid synthesis and transport, and catabolism were altered in untreated Hz animals and the expression of most of them was normalized by IGF-1 therapy; MDA was also significantly increased in the Hz untreated group. Conclusions The mere partial IGF-1 deficiency is responsible for the reduction in the expression of genes involved in glucose and lipid metabolism, resulting in dyslipidemia and hyperglycemia. Such genetic alterations may seriously contribute to the establishment of MetS.
TypeArtículo / Article
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-nd/4.0/
- Experimental approach to IGF-1 therapy in CCl<sub>4</sub>-induced acute liver damage in healthy controls and mice with partial IGF-1 deficiency.
- Authors: Morales-Garza LA, Puche JE, Aguirre GA, Muñoz Ú, García-Magariño M, De la Garza RG, Castilla-Cortazar I
- Issue date: 2017 May 4
- Prenatal ethanol exposure programs an increased susceptibility of non-alcoholic fatty liver disease in female adult offspring rats.
- Authors: Shen L, Liu Z, Gong J, Zhang L, Wang L, Magdalou J, Chen L, Wang H
- Issue date: 2014 Jan 15
- Low doses of insulin-like growth factor I improve insulin resistance, lipid metabolism, and oxidative damage in aging rats.
- Authors: García-Fernández M, Delgado G, Puche JE, González-Barón S, Castilla Cortázar I
- Issue date: 2008 May
- Mechanisms Underlying Testicular Damage and Dysfunction in Mice With Partial IGF-1 Deficiency and the Effectiveness of IGF-1 Replacement Therapy.
- Authors: Castilla-Cortázar I, Gago A, Muñoz Ú, Ávila-Gallego E, Guerra-Menéndez L, Sádaba MC, García-Magariño M, Olleros Santos-Ruiz M, Aguirre GA, Puche JE
- Issue date: 2015 Dec
- Hepatoprotection and neuroprotection induced by low doses of IGF-II in aging rats.
- Authors: Castilla-Cortázar I, García-Fernández M, Delgado G, Puche JE, Sierra I, Barhoum R, González-Barón S
- Issue date: 2011 Jul 6